JAMA Network Home
Sign In
Research Letter

US Trends in Prescribing Nonstatin Lipid-Lowering Therapy, 2019-2024

JAMA Cardiology 10.1001/jamacardio.2026.0844

April 22, 2026 at 11:00 AM EDT

Read the full article

This cross-sectional study examines trends in prescribing nonstatin lipid-lowering therapy in the US from 2019 to 2024 vs statin prescribing.

Corresponding Author: Michael J. Blaha, MD, MPH, Ciccarone Center for the Prevention of Cardiovascular Disease, Johns Hopkins University, 600 N Wolfe St, Blalock 524D1, Baltimore, MD 2287 (mblaha1@jhmi.edu).

Link to the article in your story

We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)

https://jamanetwork.com/journals/jamacardiology/fullarticle/10.1001/jamacardio.2026.0844?utm_source=for_the_media&utm_medium=referral&utm_campaign=ftm_links&utm_term=042226

Copy to clipboard

Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Need more information? Contact us.

Editor's Picks